Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs

被引:60
作者
Sacks-Davis, Rachel [1 ,2 ,3 ]
Daraganova, Galina
Aitken, Campbell [1 ,2 ,3 ]
Higgs, Peter [1 ,2 ,3 ]
Tracy, Lilly [5 ]
Bowden, Scott [5 ]
Jenkinson, Rebecca [1 ,3 ]
Rolls, David
Pattison, Philippa
Robins, Garry
Grebely, Jason [4 ]
Barry, Alyssa [6 ,7 ]
Hellard, Margaret [1 ,2 ,3 ]
机构
[1] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia
[2] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
[3] Burnet Inst, Ctr Res Excellence Injecting Drug Use, Melbourne, Vic, Australia
[4] Univ New S Wales, Kirby Inst Infect & Immun Soc, Darlinghurst, NSW, Australia
[5] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia
[6] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic, Australia
[7] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia
来源
PLOS ONE | 2012年 / 7卷 / 10期
基金
英国医学研究理事会; 澳大利亚研究理事会;
关键词
MOLECULAR EPIDEMIOLOGY; GLOBAL EPIDEMIOLOGY; USERS; INCARCERATION; HIV; TRANSMISSION; INFECTION; GENOTYPES;
D O I
10.1371/journal.pone.0047335
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
It is hypothesized that social networks facilitate transmission of the hepatitis C virus (HCV). We tested for association between HCV phylogeny and reported injecting relationships using longitudinal data from a social network design study. People who inject drugs were recruited from street drug markets in Melbourne, Australia. Interviews and blood tests took place three monthly (during 2005-2008), with participants asked to nominate up to five injecting partners at each interview. The HCV core region of individual isolates was then sequenced and phylogenetic trees were constructed. Genetic clusters were identified using bootstrapping (cut-off: 70%). An adjusted Jaccard similarity coefficient was used to measure the association between the reported injecting relationships and relationships defined by clustering in the phylogenetic analysis (statistical significance assessed using the quadratic assignment procedure). 402 participants consented to participate; 244 HCV infections were observed in 238 individuals. 26 genetic clusters were identified, with 2-7 infections per cluster. Newly acquired infection (AOR = 2.03, 95% CI: 1.04-3.96, p = 0.037, and HCV genotype 3 (vs. genotype 1, AOR = 2.72, 95% CI: 1.48-4.99) were independent predictors of being in a cluster. 54% of participants whose infections were part of a cluster in the phylogenetic analysis reported injecting with at least one other participant in that cluster during the study. Overall, 16% of participants who were infected at study entry and 40% of participants with newly acquired infections had molecular evidence of related infections with at least one injecting partner. Likely transmission clusters identified in phylogenetic analysis correlated with reported injecting relationships (adjusted Jaccard coefficient: 0.300; p<0.001). This is the first study to show that HCV phylogeny is associated with the injecting network, highlighting the importance of the injecting network in HCV transmission.
引用
收藏
页数:15
相关论文
共 50 条
  • [31] Hepatitis C virus risk among young people who inject drugs
    Mateu-Gelabert, Pedro
    Sabounchi, Nasim S.
    Guarino, Honoria
    Ciervo, Courtney
    Joseph, Kellie
    Eckhardt, Benjamin J.
    Fong, Chunki
    Kapadia, Shashi N.
    Huang, Terry T. K.
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [32] Can hepatitis C virus infection be eradicated in people who inject drugs?
    Grebely, Jason
    Dore, Gregory J.
    ANTIVIRAL RESEARCH, 2014, 104 : 62 - 72
  • [33] Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: What has been the impact of targeted free vaccination?
    Winter, Rebecca J.
    Dietze, Paul M.
    Gouillou, Maelenn
    Hellard, Margaret E.
    Robinson, Priscilla
    Aitken, Campbell K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (02) : 314 - 322
  • [34] Modeling Combination Hepatitis C Virus Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the United States
    Zelenev, Alexei
    Li, Jianghong
    Shea, Portia
    Hecht, Robert
    Altice, Frederick L.
    CLINICAL INFECTIOUS DISEASES, 2021, 72 (05) : 755 - 763
  • [35] Elimination of Hepatitis C Virus Infection Among People Who Inject Drugs Through Treatment as Prevention: Feasibility and Future Requirements
    Grebely, Jason
    Matthews, Gail V.
    Lloyd, Andrew R.
    Dore, Gregory J.
    CLINICAL INFECTIOUS DISEASES, 2013, 57 (07) : 1014 - 1020
  • [36] How cost-effective is hepatitis C virus treatment for people who inject drugs?
    Martin, Natasha K.
    Vickerman, Peter
    Miners, Alec
    Hickman, Matthew
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 (04) : 590 - 592
  • [37] Gender differences in planning ability and hepatitis C virus among people who inject drugs
    Scheidell, J. D.
    Khan, M. R.
    Clifford, L. M.
    Dunne, E. M.
    Keen, L. D., II
    Latimer, W. W.
    ADDICTIVE BEHAVIORS, 2015, 47 : 33 - 37
  • [38] Injecting risk behaviours following treatment for hepatitis C virus infection among people who inject drugs: The Australian Trial in Acute Hepatitis C
    Alavi, Maryam
    Spelman, Tim
    Matthews, Gail V.
    Haber, Paul S.
    Day, Carolyn
    van Beek, Ingrid
    Walsh, Nick
    Yeung, Barbara
    Bruneau, Julie
    Petoumenos, Kathy
    Dolan, Kate
    Kaldor, John M.
    Dore, Gregory J.
    Hellard, Margaret
    Grebely, Jason
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (10) : 976 - 983
  • [39] Hepatitis C virus seroprevalence among people who inject drugs and factors associated with infection in eight Russian cities
    Heimer, Robert
    Eritsyan, Ksenia
    Barbour, Russell
    Levina, Olga S.
    BMC INFECTIOUS DISEASES, 2014, 14
  • [40] Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
    Grebely, Jason
    Bruggmann, Philip
    Treloar, Carla
    Byrne, Jude
    Rhodes, Tim
    Dore, Gregory J.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (10) : 893 - 898